Gerren McHam on the Future of US Pharma Reshoring

Why It Matters

For manufacturers, pharma reshoring raises questions about where production capacity, labor, and supplier networks will be built. Investors and supply chain teams would focus on whether U.S.-based pharma production can support durable margins and reliable inputs.